{"id":247013,"date":"2026-09-15T14:18:46","date_gmt":"2026-09-15T08:48:46","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=247013"},"modified":"2026-09-15T14:18:46","modified_gmt":"2026-09-15T08:48:46","slug":"gland-pharma-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/","title":{"rendered":"Is Gland Pharma the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Gland Pharma CMP Rs 2,905 (15 Sep 2026). Market cap Rs 48,215 Cr. ROE 9.92%. P\/E 42.71x versus Industry P\/E 37.96x.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Gland Pharma is one of the names investors compare when screening the Healthcare sector, built on a 9.92% return on equity and a P\/E of 42.71x against an Industry P\/E of 37.96x. Gland Pharma Ltd manufactures complex injectable formulations and provides contract development and manufacturing (CDMO) services to pharmaceutical companies globally, with a majority stake held by China&#8217;s Fosun Pharma. Whether Gland Pharma is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n<p>Is <a href=\"https:\/\/univest.in\/stocks\/gland\/gland-pharma-ltd-share-price-today\">Gland Pharma<\/a> the best stock in its sector? The stock trades on the NSE at Rs 2,905 as of 15 September 2026, within its 52-week range of Rs 1,573.60 to Rs 3,042.00. Gland Pharma Ltd manufactures complex injectable formulations and provides contract development and manufacturing (CDMO) services to pharmaceutical companies globally, with a majority stake held by China&#8217;s Fosun Pharma.<\/p>\n<p>Gland Pharma sits in the Healthcare sector, and its 9.92% ROE and 42.71x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector&#8217;s Industry P\/E benchmark.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/abbott-india-best-stock-in-its-sector\">Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=gland-pharma-best-stock-in-its-sector\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#About_Gland_Pharma\" title=\"About Gland Pharma\">About Gland Pharma<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#Is_Gland_Pharma_the_Best_Stock_in_Its_Sector\" title=\"Is Gland Pharma the Best Stock in Its Sector?\">Is Gland Pharma the Best Stock in Its Sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#How_Gland_Pharma_Compares_Against_Its_Healthcare_Sector_Peers\" title=\"How Gland Pharma Compares Against Its Healthcare Sector Peers\">How Gland Pharma Compares Against Its Healthcare Sector Peers<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#What_Makes_Gland_Pharma_Worth_Watching_in_Healthcare\" title=\"What Makes Gland Pharma Worth Watching in Healthcare\">What Makes Gland Pharma Worth Watching in Healthcare<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#Gland_Pharma_Valuation_Is_It_Justified\" title=\"Gland Pharma Valuation: Is It Justified?\">Gland Pharma Valuation: Is It Justified?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#How_to_Track_Gland_Pharma_Before_You_Invest\" title=\"How to Track Gland Pharma Before You Invest\">How to Track Gland Pharma Before You Invest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#Is_Gland_Pharma_the_best_stock_in_its_sector\" title=\"Is Gland Pharma the best stock in its sector?\">Is Gland Pharma the best stock in its sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#What_is_the_current_share_price_of_Gland_Pharma\" title=\"What is the current share price of Gland Pharma?\">What is the current share price of Gland Pharma?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#What_sector_does_Gland_Pharma_belong_to\" title=\"What sector does Gland Pharma belong to?\">What sector does Gland Pharma belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#How_does_Gland_Pharma_compare_to_its_sector_peers_on_PE\" title=\"How does Gland Pharma compare to its sector peers on P\/E?\">How does Gland Pharma compare to its sector peers on P\/E?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#What_is_Gland_Pharmas_return_on_equity\" title=\"What is Gland Pharma&#8217;s return on equity?\">What is Gland Pharma&#8217;s return on equity?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/gland-pharma-best-stock-in-its-sector\/#Should_I_invest_in_Gland_Pharma_based_on_its_sector_position\" title=\"Should I invest in Gland Pharma based on its sector position?\">Should I invest in Gland Pharma based on its sector position?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Gland_Pharma\"><\/span><strong>About Gland Pharma<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma Ltd manufactures complex injectable formulations and provides contract development and manufacturing (CDMO) services to pharmaceutical companies globally, with a majority stake held by China&#8217;s Fosun Pharma. At a market capitalisation of Rs 48,215 Cr, it is tracked as part of the Healthcare sector on Univest.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Is_Gland_Pharma_the_Best_Stock_in_Its_Sector\"><\/span><strong>Is Gland Pharma the Best Stock in Its Sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma makes its case as the best stock in its sector primarily on valuation relative to its Industry P\/E, combining a 9.92% ROE with a 42.71x P\/E against the sector&#8217;s 37.96x Industry P\/E. Gland Pharma&#8217;s 42.71x P\/E is close to the 37.96x Industry P\/E, though its 9.92% ROE trails both Global Health and the MNC pharma peers used elsewhere in this series.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Metric<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Gland Pharma<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">CMP (NSE)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 2,905.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">52-Week High \/ Low<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 3,042.00 \/ Rs 1,573.60<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Market Cap<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 48,215 Cr<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/E (TTM) vs Industry P\/E<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">42.71x vs 37.96x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">P\/B<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">4.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">ROE<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">9.92%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">EPS (TTM)<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">Rs 68.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Dividend Yield<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\">Debt to Equity<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.03<\/td>\n<\/tr>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Compare Gland Pharma Against Other Healthcare Sector Stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Gland_Pharma_Compares_Against_Its_Healthcare_Sector_Peers\"><\/span><strong>How Gland Pharma Compares Against Its Healthcare Sector Peers<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table below sets Gland Pharma against 3 other Healthcare sector names, using the same live data source for every company. A peer average row is included for P\/E, ROE and debt to equity, calculated across the 3 peer companies.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\">\n<tr>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Company<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">P\/E<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #ddd;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/gland\/gland-pharma-ltd-share-price-today\">Gland Pharma<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">48,215<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">42.71<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">9.92%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.03<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/medanta\/global-health-ltd-share-price-today\">Global Health<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">38,921<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">70.47<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">14.05%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.30<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/pfizer\/pfizer-ltd-share-price-today\">Pfizer<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">18,583<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">25.28<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">17.19%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sanofiind\/sanofi-india-ltd-share-price-today\">Sanofi India<\/a><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">7,093<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">21.91<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">39.20%<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">0.02<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>Peer average (3 companies)<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\">&#8211;<\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>39.22<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>23.48%<\/strong><\/td>\n<td style=\"border:1px solid #ddd;padding:8px;\"><strong>0.11<\/strong><\/td>\n<\/tr>\n<\/table>\n<p>Against this peer set, Gland Pharma&#8217;s 9.92% ROE is below the 23.48% peer average, and its P\/E of 42.71x runs above the peer average of 39.22x. Gland Pharma&#8217;s 42.71x P\/E is close to the 37.96x Industry P\/E, though its 9.92% ROE trails both Global Health and the MNC pharma peers used elsewhere in this series.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_Makes_Gland_Pharma_Worth_Watching_in_Healthcare\"><\/span><strong>What Makes Gland Pharma Worth Watching in Healthcare<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Near debt free balance sheet:<\/strong> A debt to equity ratio of 0.03 gives Gland Pharma flexibility to invest in new manufacturing capacity.<\/li>\n<li><strong>Specialised injectables and CDMO focus:<\/strong> Concentrating on complex injectables and contract manufacturing differentiates Gland Pharma from generic oral-solid formulation makers.<\/li>\n<li><strong>Slight premium to Industry P\/E:<\/strong> A 42.71x P\/E against a 37.96x Industry P\/E is a modest premium for its specialised manufacturing capability.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Gland_Pharma_Valuation_Is_It_Justified\"><\/span><strong>Gland Pharma Valuation: Is It Justified?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma&#8217;s 42.71x P\/E is close to the 37.96x Industry P\/E, though its 9.92% ROE trails both Global Health and the MNC pharma peers used elsewhere in this series. As with any single stock, investors should weigh this against their own valuation discipline and risk appetite rather than the sector label alone.<\/p>\n<p style=\"font-style:italic;color:#000000;margin:14px 0;\">Also read &#8211; <a href=\"https:\/\/univest.in\/blogs\/bata-india-best-stock-in-its-sector\">Is Bata India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Gland Pharma and other Healthcare sector stocks.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Track_Gland_Pharma_Before_You_Invest\"><\/span><strong>How to Track Gland Pharma Before You Invest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Before deciding whether Gland Pharma deserves its label as the best stock in its sector for your own portfolio, compare it directly against Healthcare sector peers using the steps below.<\/p>\n<ol>\n<li>Open the Univest Screener and search for Gland Pharma to view live price, valuation ratios, and peer comparisons within the Healthcare sector.<\/li>\n<li>Compare its P\/E, P\/B, and ROE against other Healthcare sector stocks before deciding if the current valuation fits your strategy.<\/li>\n<li>Set a price alert around key support and resistance zones using the Univest app so you are notified of meaningful moves.<\/li>\n<li>Open a broking account on Univest if you decide to add the stock, and size the position based on your own risk appetite and portfolio allocation.<\/li>\n<\/ol>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Gland Pharma earns a place in the best stock in its sector conversation on the strength of a 9.92% ROE and a P\/E of 42.71x against a 37.96x Industry P\/E, with named peer comparisons in this article backing up that picture. As with any individual stock decision, this analysis is educational and investors should do their own research or consult a SEBI-registered advisor before investing.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h3><span class=\"ez-toc-section\" id=\"Is_Gland_Pharma_the_best_stock_in_its_sector\"><\/span><strong>Is Gland Pharma the best stock in its sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma has a 9.92% ROE and trades at 42.71x P\/E against a 37.96x Industry P\/E, and compares below the peer average ROE of 23.48% in this article&#8217;s named comparison, so the answer depends on what an investor is prioritising.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_share_price_of_Gland_Pharma\"><\/span><strong>What is the current share price of Gland Pharma?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma was trading at Rs 2,905.00 on the NSE as of 15 September 2026, within its 52-week range of Rs 1,573.60 to Rs 3,042.00.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Gland_Pharma_belong_to\"><\/span><strong>What sector does Gland Pharma belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma is classified under the Healthcare sector on Univest.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Gland_Pharma_compare_to_its_sector_peers_on_PE\"><\/span><strong>How does Gland Pharma compare to its sector peers on P\/E?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma&#8217;s P\/E of 42.71x is above the 39.22x average of the 3 named peers compared in this article.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Gland_Pharmas_return_on_equity\"><\/span><strong>What is Gland Pharma&#8217;s return on equity?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma reported a return on equity of 9.92%, which is below the 23.48% average of its named peers in this comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_invest_in_Gland_Pharma_based_on_its_sector_position\"><\/span><strong>Should I invest in Gland Pharma based on its sector position?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Gland Pharma&#8217;s sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Is Gland Pharma the best stock in its sector?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma has a 9.92% ROE and trades at 42.71x P\/E against a 37.96x Industry P\/E, and compares below the peer average ROE of 23.48% in this article's named comparison, so the answer depends on what an investor is prioritising.\"}},{\"@type\":\"Question\",\"name\":\"What is the current share price of Gland Pharma?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma was trading at Rs 2,905.00 on the NSE as of 15 September 2026, within its 52-week range of Rs 1,573.60 to Rs 3,042.00.\"}},{\"@type\":\"Question\",\"name\":\"What sector does Gland Pharma belong to?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma is classified under the Healthcare sector on Univest.\"}},{\"@type\":\"Question\",\"name\":\"How does Gland Pharma compare to its sector peers on P\/E?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma's P\/E of 42.71x is above the 39.22x average of the 3 named peers compared in this article.\"}},{\"@type\":\"Question\",\"name\":\"What is Gland Pharma's return on equity?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma reported a return on equity of 9.92%, which is below the 23.48% average of its named peers in this comparison.\"}},{\"@type\":\"Question\",\"name\":\"Should I invest in Gland Pharma based on its sector position?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Gland Pharma's sector position and metrics make it worth researching further, but any investment decision should factor in your own risk appetite, its valuation relative to peers, and independent research or advice from a SEBI-registered advisor.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Is Gland Pharma the best stock in its sector? A data-backed look at its ROE, valuation and named Healthcare sector peer comparison.<\/p>\n","protected":false},"author":29,"featured_media":247012,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-247013","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["247012"],"rank_math_title":["Gland Pharma: Best Stock in Its Sector? Key Metrics"],"rank_math_description":["Is Gland Pharma the best stock in its sector? Check CMP, ROE, PE versus Industry PE, debt levels and peer comparisons before deciding on this Healthcare sector stock."],"rank_math_focus_keyword":["best stock in its sector"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/gland-pharma-best-stock-in-its-sector.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/247013","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=247013"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/247013\/revisions"}],"predecessor-version":[{"id":247014,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/247013\/revisions\/247014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/247012"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=247013"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=247013"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=247013"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}